FDA Drug recall D-0029-2025
Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24
- FDA Drug
- Class II
- terminated
- Published 2024-11-06
On 2024-11-06 the FDA classified a Class II recall of Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24 by Bli International, citing superpotent Drug: Stability failure for assay at 6 months test time-point.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0029-2025 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-10-21 |
| Published | 2024-11-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Bli International |
| Distribution | MO, OH |
Product
Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24
Reason
Superpotent Drug: Stability failure for assay at 6 months test time-point.
Identifiers
| ndc | 53185-277-24 |
|---|---|
| code_info | Lot # 24A27724, Exp 01/31/2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0029-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.